Sterile barriers "not packaging" says industry:
This article was originally published in Clinica
Executive Summary
Sterile barrier systems should not be considered as packaging and not be regulated under the Packaging and Packaging Waste Directive. This is the message that Eucomed is aiming to convey to the European Commission. It is currently collecting details to support its argument and has posted a questionnaire on its website to help collate information. It is considering the argument that sterile barrier systems are part of, or an accessory to, medical devices and should therefore be regulated under the Medical Devices Directive (MDD). Eucomed is looking closely now at existing assessment of sterile barrier systems/materials under the MDD.
You may also be interested in...
Ratio Therapeutics On BMS Investment, Radiopharma R&D Trends, AI Use
The CEO and CSO of radiopharmaceutical company Ratio Therapeutics, which now has Bristol Myers Squibb as an investor, talk about Ratio’s R&D platforms, use of AI, an independent FAP-targeted asset and trends in radiopharma research such as combining other modalities like ADCs, in this podcast interview with Scrip
With One Launch Under Way, SpringWorks Ramps Up For A Second
The company initiated a rolling submission with the US FDA for mirdametinib, a MEK inhibitor that is poised to be its second commercial product for a rare disease.
Finance Watch: Ten IPOs So Far In 2024, But Returns To Date Are Subpar
Public Company Edition: This year’s newly public companies are trading an average of 9.7% below their IPO prices, including the two most recent debuts, Boundless Bio and Contineum. Also, Nkarta, Praxis and Nurix grossed $240m, $200m and $175m, respectively, in follow-on offerings.